Coherus Oncology Inc (CHRS)

Stock-Based Compensation

$4.97M

Quarterly · Period ending: · USD

CHRS logo

CHRS Stock-Based Compensation

Latest reported$4.97M
CHRS Quarterly Stock-Based Comp ($882.00K → $4.97M)
High-resolution chart · PNG

CHRS stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
4,968,000
2,385,000
10,793,000
3,389,000
5,421,000
5,372,000
6,384,000
6,868,000
0
7,319,000
10,798,000
9,953,000
10,077,000
12,282,000
11,726,000
12,282,000
13,850,000
12,879,000
0
11,939,000
11,595,000
16,884,000
9,873,000
9,307,000
9,425,000
0
7,272,000
8,833,000
7,992,000
9,494,000
8,827,000
8,560,000
8,690,000
8,720,000
11,000,000
8,183,000
9,072,000
7,810,000
7,685,000
8,270,000
6,148,000
5,318,000
5,174,000
4,744,000
4,621,000
2,182,000
3,826,000
2,735,000
1,210,000
3,291,000
311,000
998,000
7,247,000
882,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.